Tocagen (TOCA) Tops Q4 EPS by 8c

Tocagen (NASDAQ: TOCA) reported Q4 EPS of ($0.55), $0.08 better than the analyst estimate of ($0.63). Licensing revenue for the quarter came in at $10 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Tocagen (TOCA) click here.

You May Also Be Interested In

• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• Acme United (ACU) Misses Q1 EPS by 20c
• PPG Industries (PPG) Reports In-Line Q1 EPS, offers outlook